Prajita Pandey

Prajita Pandey

Dr. Prajita Pandey is a skilled analytical chemist with deep expertise in analytical and bioanalytical method development. She currently serves as Associate Director of the Chemistry Department at Emery Pharma. Since joining Emery Pharma in 2020, she has played a pivotal role in expanding the company’s protein characterization and biologics analysis capabilities.

Related Posts:

Exploring Covalently Bonded Protein-Small Molecule Complexes with High-Resolution Mass Spectrometry

March 27, 2025

The analysis of proteins covalently linked to small molecules has become a cornerstone of drug discovery, therapeutic development, and biological research. These small molecules can form stable, irreversible complexes with proteins through covalent bonding, often affecting the protein’s function, stability,…

The Critical Role of Bioanalytical Platform Selection: Ligand-Binding Assays vs Mass Spectrometry

September 19, 2024

The selection of a bioanalytical platform is critical because it directly influences the accuracy, sensitivity, and specificity of the data generated, which in turn guides decision-making in drug development. A well-chosen platform ensures reliable quantification and characterization of biomolecules, minimizes…

Native Mass Spectrometry (Native-MS) for Aggregate and Charge Variant Analysis

April 29, 2024

Size exclusion chromatography (SEC) and ion exchange chromatography (IEX) are traditional methods utilized for characterizing biotherapeutics under non-denaturing conditions. The typical high salt concentrations in their mobile phases make them incompatible with mass spectrometry (MS) detection. Native-MS stands out as…